Farmanews.com

Especialidades y enfermedades  
Farmacéuticas

Farmacéuticas. 21 de septiembre de 2017

Envigo appoints Chief Commercial Officer and President of EMEA Operations

Princeton, NJ, September 21, 2017: Envigo announced today that it has made two new appointments to its Executive Committee. The appointments of a Chief Commercial Officer and President of EMEA Operations have been made at a time of growth for Envigo during which the organization has been focused on improving the quality of the customer experience for its global customer base across the pharmaceutical, chemicals, and crop protection industries. Both of the positions report directly into Dr. Adrian Hardy, Chief Executive Officer of Envigo.
Acceder
Farmacéuticas. 11 de septiembre de 2017

Piramal Pharma Solutions Names John Fowler as its Chief Operating Officer

MUMBAI, September 8, 2017: Piramal Pharma Solutions (PPS), part of Piramal Enterprises Limited, announce the appointment of John Fowler as its Chief Operating Officer. PPS is a leader in Integrated Contract Development and Manufacturing, with a global network of 12 development and manufacturing facilities across North America, Europe and Asia. PPS offers a comprehensive range of services including Drug Discovery Solutions, Process & Pharmaceutical Development services, Clinical Trial Supplies and Commercial supply of APIs and Finished dosage forms. As Chief Operating Officer, John will be responsible for Global Operations and Research & Development (R&D), and will play a lead role in ensuring that our customers consistently experience differentiated and excellent levels of service.
Acceder
Farmacéuticas. 01 de septiembre de 2017

Jesper Ericsson appointed new CEO of Symcel

Symcel Sverige AB today announces the appointment of Jesper Ericsson as new Chief Executive Officer – succeeding Christer Wallin, who is now retiring.
Acceder
Farmacéuticas. 15 de agosto de 2017

The Asian giant Pharma event surpasses 55,000 visits with more than 10,000 overseas visits

Amsterdam, 15th August 2017: CPhI and P-MEC China, organised by UBM EMEA, UBM Sinoexpo and China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), closed in June 2017 with a very successful show, reporting a positive outlook for the Chinese pharmaceutical market’s development. Since 2016, CPhI China has experienced a 14% growth in overall visits and a 12% growth in overseas visits – a remarkable achievement for a mature market with 17 previous editions behind it.
Acceder
Farmacéuticas. 10 de agosto de 2017

CPhI India Report identifies two-tier manufacturing market and predicts increased acquisitions

Amsterdam, 10th August 2017: CPhI release the findings the 2017 India Pharma Market Report, which identified a two-tier manufacturing market and forecast increased acquisitions by Indian companies, along with a notable improvement in the international reputation of Indian made pharmaceuticals. But perhaps most dramatically, a large majority of domestic companies called for urgent Government support to invest in API sites. 
Acceder
Farmacéuticas. 31 de julio de 2017

WuXi’s Pharmaceutical Development Services Division Merges with STA

Shanghai, July 31, 2017: STA Pharmaceutical Co., Ltd. (STA) – a WuXi AppTec group company and the leading open-access capability and technology platform for small molecule pharmaceutical development and manufacturing – announces that it has merged with WuXi AppTec’s Pharmaceutical Development Services (PDS) division.
Acceder
Farmacéuticas. 27 de julio de 2017

Teklad Diets recertified to new ISO standard

Princeton, NJ, July 27, 2017 – Envigo has announced that its Teklad Diets sites in Madison, WI received recertification to the new ISO9001:2015 standard. ISO 9001 is the international standard that specifies requirements for a quality management system (QMS). Organizations use the standard to demonstrate the ability to consistently provide products and services that meet customer and regulatory requirements. The ISO9001:2015 revision has re-focused on performance by combining the process approach with risk-based thinking and employing the Plan-Do-Check-Act cycle at all levels within an organization. Received in June, this certification gives Envigo’s customers’ confidence about the oversight and quality of the products they purchase for their research needs.
Acceder
Farmacéuticas. 27 de julio de 2017

CPhI Annual Reports - how accurate were they 5 years on?

Amsterdam, 27 July 2017: CPhI Worldwide, organized by UBM announces the 2017 expert panel for the highly anticipated CPhI Worldwide Annual Industry Report (5th edition) – to be released in two parts; part one in late summer and part two during CPhI Worldwide (October 24-26, 2017 in Frankfurt). The report is a comprehensive and critically important publication that analyses key trends and innovations forecast by a panel of world class experts.
Acceder

Subir  

Subir notas de prensa y convocatorias

Próximas convocatorias   

No hay próximas convocatorias
Ver todas

Especialidades  

Busca notas de prensa por especialidad médica o enfermedad.



Ver todas

Archivo  

Busca notas de prensa por su fecha de edición.

  Selecciona el año


Copyright © 2017, Farmavet, S.L. Todos los derechos reservados.